Next Article in Journal
[1,2,5]Thiadiazolo[3,4-d]Pyridazine as an Internal Acceptor in the D-A-π-A Organic Sensitizers for Dye-Sensitized Solar Cells
Next Article in Special Issue
Topical Application of Cinnamaldehyde Promotes Faster Healing of Skin Wounds Infected with Pseudomonas aeruginosa
Previous Article in Journal
Evaluation of Polyphenolic Compounds and Pharmacological Activities in Hairy Root Cultures of Ligularia fischeri Turcz. f. spiciformis (Nakai)
Previous Article in Special Issue
Antibacterial and Biofilm Inhibitory Activity of Medicinal Plant Essential Oils Against Escherichia coli Isolated from UTI Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Anticandidal Potential of Stem Bark Extract from Schima superba and the Identification of Its Major Anticandidal Compound

1
Xiamen Key Laboratory of Traditional Chinese Medicine Bio-engineering, Xiamen Medical College, Xiamen 361023, China
2
Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University, Xiamen Medical College, Xiamen 361023, China
3
Department of Medical Technology, Xiamen Medical College, Xiamen 361023, China
4
Application Technique Engineering Center of Natural Cosmeceuticals, College of Fujian Province, Xiamen Medical College, Xiamen 361023, China
5
Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China
*
Authors to whom correspondence should be addressed.
Molecules 2019, 24(8), 1587; https://doi.org/10.3390/molecules24081587
Submission received: 2 March 2019 / Revised: 18 April 2019 / Accepted: 22 April 2019 / Published: 22 April 2019
(This article belongs to the Special Issue Antimicrobial Properties of Natural Products)

Abstract

:
Plant-derived extracts are a promising source of new drugs. Schima superba is traditionally used in China for heat clearing, detoxification, and treatment of furuncles. In this study, the anticandidal properties and mechanism of action of S. superba (SSE) were explored using a stem bark extract. SSE possessed high polyphenol and saponin contents of 256.6 ± 5.1 and 357.8 ± 31.5 µg/mg, respectively. A clear inhibition zone was observed for C. albicans growth through the disc diffusion method and the 50% inhibition of C. albicans by SSE was 415.2 µg/mL. Transcriptomic analysis in C. albicans treated with different doses of SSE was conducted through RNA-seq. Average values of 6068 genes and 20,842,500 clean reads were identified from each sample. Among these samples, 1680 and 1956 genes were differentially expressed genes (DEGs) from the SSE treatments of 0.2 and 0.4 mg/mL, respectively. C. albicans growth was inhibited by the changes in gene expression associated with the cell wall and membrane composition including the regulation of chitin degradation and ergosterol biosynthesis. This result could be reflected in the irregularly wrinkled morphology of the ruptured cell as revealed through SEM analysis. ESI-MS and NMR analyses revealed that the major compound purified from SSE was sasanquasaponin III and the 50% inhibition of C. albicans was 93.1 µg/mL. In summary, the traditional Chinese medicine S. superba can be applied as an anticandidal agent in complementary and alternative medicine.

Graphical Abstract

1. Introduction

Schima superba Gardn. et Champ. (Theaceae) is a dominant broad-leaved evergreen tree widely distributed in the subtropical regions of China. This traditional Chinese medicine is used for heat clearing, detoxification, and furuncle treatment; it is also used as an insecticide agent [1]. The root and stem bark of S. superba can dispel wind dampness, relieve pain, serve as an emetic, and induce diuresis for removing edema [2]. Bioactive compounds from S. superba have been widely explored. An abundance of phenolics in S. superba with antimicrobial and antioxidant potential was noted [3,4]. Some saponins from S. superba leaves have antifungal effects against Magnaporthe oryzae, which can cause a highly damaging disease in rice [5,6]. They were identified as two oleanane-type triterpenoid saponins, schimasuoside A (1) and schimasuoside B (2) [6]. Two compounds, namely, (7R,8S)-1-(3,4-dimethoxyphenyl)-2-O-(2-methoxy-4-ω-hydroxypropylphenyl)propane-1,3-diol and threo-1-(4-hydroxy-3-methoxy- phenyl)-1-methoxy-2-{4-[1-formyl-(E)-vinyl]-2-methoxyphenoxy}-3-propanol, characterized from the stems of S. superba, have inhibitory activities against some human cancer cell lines [7]. Eight oleanane-type triterpenoid saponins, that is, schisusaponins A–H, have also been identified from the root bark of S. superba; among them, schisusaponins C and E exhibit cytotoxicity on the B16 melanoma cell line with IC50 values of 10.08 and 10.89 mM, respectively [8].
Candida albicans is a major opportunistic fungal pathogen in humans that can induce superficial and severe infections in individuals or immunocompromised hosts [9]. Well-known antifungal agents, such as the azoles, including imidazoles and triazoles, are generally utilized to treat infections [10]. They inhibit lanosterol 14-α-demethylase in the biosynthesis of ergosterol, a major component of fungal membrane [11]. However, drug-resistant isolates have emerged because of the widespread overuse of azole drugs [12]. Hence, the antimicrobial activity of plant-derived substances, which can be developed as sources of new drugs, has been studied [13]. Anticandidal susceptibility is exhibited by various extracts derived from different plants, such as Anagallis arvensis L. (Primulaceae), Sideroxylon obtusifolium T. D. Penn (Sapotacea), Syzygium cumini (L.) Skeels (Myrtaceae), Combretum zeyheri, Hosta plantaginea (Lam.) Aschers, and ornamental tobacco [14,15,16,17,18]. The extracts with potent activity against C. albicans include saponins such as anagallisin C, hostaside I, and hostaside II, and peptides, such as NaD1 defensin.
In this study, an extract from the stem bark of S. superba, designated as S. superba extract (SSE) was used to evaluate the antimicrobial activity. SSE was subjected to anticandidal susceptibility testing, and RNA-seq analysis of C. albicans at different SSE doses was conducted for molecular examination. The morphological characteristics of C. albicans were detected through scanning electron microscopy (SEM) to investigate the effect of SSE. In addition, the component of SSE was identified and quantified through ultraperformance liquid chromatography (UPLC), electrospray ionization mass spectrometry (ESI-MS), and nuclear magnetic resonance (NMR). Sasanquasaponin III purified from SSE was also evaluated for its anticandidal ability.

2. Results

2.1. Antioxidant Activity of SSE

The antioxidant activity of SSE was analyzed through DPPH and ABTS+ radical scavenging assays. SSE exhibited a high antioxidant activity (Figure 1) and scavenged DPPH and ABTS+ radical and the positive control of ascorbic acid (purity > 99%) in a dose-dependent manner. Regression analysis revealed that the inhibition rate of DPPH radicals was 50% at 0.11 mg/mL SSE. When the SSE concentration was increased to 0.25 mg/mL, the inhibition of DPPH radicals was over 80%. A similar result was obtained from the ABTS+ radical scavenging assay. The addition of 0.0625 mg/mL SSE significantly arrested ABTS+ to 64.7%. More than 90% scavenging rate of ABTS+ was achieved with 0.5 mg/mL SSE treatment.

2.2. Antimicrobial Assay of SSE

The response of four bacterial and yeast pathogens was determined through the disc diffusion method to comprehensively detect the antimicrobial ability of SSE. No evident clear zone was observed in the bacterial pathogens, including Escherichia coli, Klebsiella oxytoca, and Staphylococcus aureus (data not shown). Conversely, C. albicans was susceptible to SSE, and an clear antifungal zone could be observed when 0.0625 mg of SSE was added (Figure 2). Different SSE concentrations (0, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, and 2 mg/mL) were added to the liquid culture of C. albicans at 37 °C for 24 h of cultivation to detect the half maximal inhibitory concentration of SSE. SSE obviously inhibited C. albicans growth in a dose-dependent manner (Figure 3). A 74.1% inhibition rate of C. albicans was attained with 0.5 mg/mL SSE treatment. The 50% inhibition of C. albicans by SSE was calculated at 415.2 µg/mL SSE.

2.3. Total Polyphenol and Saponin Determination of SSE

The total polyphenol content of SSE was determined using Folin–Ciocalteu method. SSE contained 256.6 ± 5.1 µg/mg corresponding to gallic acid (purity > 98%) according to the absorbance measured at 760 nm. The total saponin content of SSE was measured by determining the absorbance at 548 nm. The result showed that SSE contained 357.8 ± 31.5 µg/mg corresponding to oleanic acid (purity > 98%).

2.4. RNA-seq Analysis of C. Albicans with SSE Treatment

C. albicans was treated with SSE at 0, 0.2, and 0.4 mg/mL for RNA-seq analysis. An average of 20,842,500 clean reads was obtained from each sample with duplication. After quality filtering and trimming, an average of 92.91% clean reads was mapped to the reference genome of C. albicans SC5314, indicating that the samples were comparable. Pearson correlation coefficients were determined to reflect the gene expression correlation between the two samples. The duplication of the same treatment had a high correlation with an average of 0.97. The RNA-seq reads were deposited in the NCBI SRA under the accession numbers BioProject PRJNA475454 and SRA SRP150296.
The RNA sequencing results showed that an average of 6068 genes was detected in these samples. The volcano plots of the DEGs revealed that 1680 and 1956 genes in C. albicans were differentially expressed after receiving 0.2 and 0.4 mg/mL SSE, respectively, and either an increase or decrease of more than twofold change was observed (Figure 4). The amount of downregulated genes increased when the SSE concentration was increased. Similar results of 252 downregulated genes and 63 upregulated genes were obtained by comparing 0.2 and 0.4 mg/mL SSE treatment, respectively.
The 15 most upregulated and downregulated genes by the SSE treatment in a dose-dependent manner are presented in Supplementary Material Tables S1 and S2. The downregulated genes have various molecular functions, such as involvement in oxidoreductase activity, monooxygenase activity, membrane channel activity, transporter activity, metal ion, nicotinamide adenine dinucleotide phosphate (NADP), adenosine triphosphate (ATP), and heme binding. By contrast, the 15 most upregulated genes are associated with major facilitator superfamily (MFS) transporter, superoxide dismutase (SOD), phenylpyruvate decarboxylase, chitinase, NADPH dehydrogenase, methylglyoxal catabolic process, and phosphate transporter.
Well-known antifungal drugs, such as azoles, can regulate C. albicans, and arrest the fungal ergosterol biosynthesis pathway and multidrug transporter genes responding to the resistance of azole antifungal agents [11,19]. Therefore, the effects of SSE on the genes involved in ergosterol biosynthesis pathway and multidrug transporter are shown in Table 1. Another two genes encoding C-5 sterol desaturase and methylsterol monooxygenase with over a twofold change were significantly downregulated in the sterol biosynthesis pathway. Two genes related to the MFS (MDR1 and HOL1) for multidrug resistance protein were upregulated with the increase in SSE treatment. The fungal cell wall is necessary to maintain cell morphology against environmental stress [20]. Nevertheless, upregulated (CHT1 and CHT4) and downregulated (CHT2) the genes involved in chitin degradation were also observed. Eight genes comprising four upregulated and four downregulated genes were selected for real-time RT-PCR to confirm the RNA-seq results. The expression levels obtained through real-time RT-PCR were consistent with the change in RNA-seq in a dose-dependent manner (Table S3).

2.5. SEM of C. Albicans with SSE Treatment

SEM micrographs are shown in Figure 5 to illustrate the effect of SSE against C. albicans cells. A typical C. albicans cell treated with SSE showed an oval and smooth appearance as compared with the control. Our results also revealed a mucilaginous material that could be a polysaccharide secreted for biofilm synthesis. Nevertheless, after 40 h of SSE exposure on an agar plate with 0.25 mg/mL, the treated cells appeared to be irregularly wrinkled and had completely collapsed. A clear broken hole was also observed in the ruptured cell.

2.6. Saponin Identification from SSE by UPLC, ESI-MS and NMR Analyses

SSE was further utilized to purify the fraction and confirm the bioactive substance working against C. albicans. SSE was subjected to UPLC analysis, and a major peak was observed at a retention time of 15.4 min (Figure 6).
The dominant compound 1 was examined through NMR and ESI-MS analyses. The result indicated the following characteristics of C59H94O26; [ α ] D 25 -18.1 (c 0.30, MeOH), ESI-MS m/z 1217.9 [M-H] (Figure S1), 1H-NMR (C5D5N, 600 MHz) (Figure S2), and 13C-NMR (C5D5N, 125 MHz) (Table 2, Figure S3). The MS and NMR data of the compound were compared with those in previous studies, and sasanquasaponin III was thus identified (Figure 7) [21].
Sasanquasaponin III was harvested through TLC and preparative HPLC to verify its anticandidal activity. C. albicans was used for determination by disc diffusion method, and different sasanquasaponin III concentrations were used for half maximal inhibitory concentrations. The results revealed that an evident clear zone was found when 0.0625 mg was added (Figure 8). Sasanquasaponin III significantly inhibited C. albicans growth in a dose-dependent manner (Figure 9). After 0.25 mg/mL sasanquasaponin III was administered at 37 °C for 24 h, a 94.9% inhibition rate of C. albicans was achieved. The 50% inhibition of C. albicans by sasanquasaponin III was calculated at 93.1 µg/mL.

3. Discussion

Plant-derived extracts have been studied for new drug development. C. albicans is susceptible to 142 natural products according to 111 research documents filed between 1969 and 2015 [13]. S. superba is widely distributed in southeast China and composed of bioactive ingredients that can be applied in cancer cell lines [7,8]. Therefore, the valuable substances from S. superba are worthy of being explored. In the present research, the SSE extract obtained from the stem bark of S. superba exhibited antioxidant and anticandidal activities. SSE possessed high polyphenolic compounds corresponding to DPPH and ABTS+ radical scavenging assays (Figure 1) [3]. To the best of our knowledge, the antimicrobial activity of S. superba extract has not been investigated. Here, SSE exhibited a dose-dependent anticandidal effect (Figure 2). However, no bacteria, such as bacterial pathogens, including E. coli, K. oxytoca, and S. aureus, were sensitive to SSE, as revealed by the disc diffusion method. The 50% inhibition of C. albicans was identified at 415.2 µg/mL SSE (Figure 3). Therefore, SSE could serve as a source of new drugs for C. albicans treatment.
The antifungal effect of SSE may involve multitarget and multichannel actions because SSE has multiple components. The fungal cell wall is composed of two covalently cross-linked polysaccharides, namely, β-glucan and chitin, which are responsible for its structural shape [22]. C. albicans dynamically changes the composition of the cell wall by breaking and reforming the chemical bonds of polysaccharides in response to environmental stresses [23]. Thus, the gene expression of the cell wall can be altered to reduce the stress in C. albicans. In general, the highest chitinase activity is contributed by CHT3 followed by CHT2; conversely, low chitinase activities are associated with CHT1 and CHT4 [24]. In this study, several genes involved in chitin degradation were upregulated and downregulated (Table 1). With regard to osmosis, SSE was hydrophilic and had penetrated C. albicans cells and even disturbed its gene expression. Therefore, our results were similar to those observed in micafungin (MFG) treatment, an antifungal drug in which CHT1 and CHT2 are upregulated and downregulated, respectively [24]. By contrast, CHT3 remained unaltered, whereas CHT4 was markedly upregulated after the SSE treatment. However, the low expression levels of CHT2 and CHT3 were consistent with the reports on the resistance to MFG and might be responsible for the fungal tolerance against cell wall stress.
The fungal plasma membrane is composed of a lipid bilayer embedded with proteins, cholesterol, and ergosterol. Lanosterol 14-α-demethylase is a critical enzyme involved in ergosterol biosynthesis and therefore is targeted by the widely used antifungal drugs of azoles [11]. Inhibiting lanosterol 14-α-demethylase can cause the accumulation of 14-α-methylsterols on the fungal surface, thereby changing in the permeability and rigidity of plasma membrane, and halting the fungal growth [25]. However, lanosterol 14-α-demethylase was upregulated in the current study (Table 1). Conversely, the downstream genes of ergosterol biosynthesis with C-5 sterol desaturase and methylsterol monooxygenase were significantly downregulated. Thus, SSE could interfere with certain ergosterol biosynthesis genes and reduce the composition of the cell membrane. Meanwhile, several multidrug resistance efflux transporter genes are correlated with the resistance to antifungal drugs [10]. Multidrug resistance-associated proteins, namely, CDR1 and CDR2, are involved in the mechanisms of azole efflux and were not upregulated after 24 h of treating C. albicans with itraconazole [10]. In our study, CDR1 was significantly downregulated, whereas the gene expression level of CDR2 was not changed. This result was consistent with that from itraconazole treatment but was completely different from the transcriptomic analysis of C. albicans treated with Huanglian Jiedu decoction, an aqueous extract of four herbs, namely, Coptidis Rhizoma, Scutellariae Radix, Phellodendri Cortex, and Gardeniae Fructus [26], possibly because of their different antifungal mechanisms.
SSE was sufficient to alter cellular morphology. The damage to the cell wall and the cell membrane was verified by an irregular, wrinkled, and uneven appearance as observed in C. albicans treated with 0.25 mg/mL SSE (Figure 5). SSE induced biofilm deformation and breakage of cell–cell connections. This result was similar to previous findings on C. albicans treated with the synthetic human β-defensin 3-C15 peptide and root extract of Juglans regia [27,28]. The fluctuant gene expression involved in chitin degradation and ergosterol biosynthesis was probably responsible for the morphological change in the cell wall and membrane.
Saponins have a cardioprotective potential because of their antihypoxic, calcium ion regulation/inotropic, anti-atherosclerotic, and hypolipidemic effects, anoxia/reoxygenation, cardiocyte apoptosis, and vasodilatory/cardiac depressant [29]. Additionally, saponins from plants exhibit anticandidal susceptibilities, such as anagallisin C, hostaside I, hostaside II, and CAY1, thus provide a promising evidence for their antifungal ability [14,17,30,31]. In our research, a high saponin content with 357.8 µg/mg oleanic acid was observed in SSE. Therefore, saponin was further purified from SSE, and sasanquasaponin III was identified as the major compound through UPLC analysis (Figure 6 and Figure 7). Sasanquasaponin III, a kind of triterpenoid saponin, was first isolated from the flower buds of Camellia sasanqua, which is an ornamental plant in Japan [21]. This substance inhibited the release of β-hexosaminidase from rat basophile leukemia cells at 3 µM with 51.6% inhibition rate for antiallergic activity. In addition, sasanquasaponin III can be found in the root bark of S. superba [8]. Thus, sasanquasaponin III widely exists in the stem and root of S. superba. The fungicidal effect of sasanquasaponin III on C. albicans was confirmed in this study, and the 50% inhibition of C. albicans was identified at a concentration of 93.1 µg/mL (Figure 8 and Figure 9). In general, saponins can interact with the cell wall and membrane to stimulate cell lysis [30,31,32]. RNA-seq and morphological observation showed that the anticandidal effect of SSE and sasanquasaponin III was consistent with the fungicidal property of saponin. This study was the first to characterize the anticandidal function of sasanquasaponin III.

4. Materials and Methods

4.1. Plant Material and Extraction

The dried stem bark of S. superba was collected from Sanming (longitude: 116.820837, latitude: 26.972907), Fujian, China, in March 2016 and authenticated by Prof. Ming-Jun Wang (Department of Pharmacy, Xiamen Medical College). A voucher specimen (No. MH20160311) was deposited in the Xiamen Key Laboratory of Biotechnology of Traditional Chinese Medicine, Xiamen Medical College. The dried and powdered stem bark of S. superba (2.5 kg) was soaked in 70% (v/v) ethanol (EtOH) at room temperature thrice (3 × 6 L) for 2 h at each time. The EtOH solution was filtered and concentrated under reduced pressure to yield a crude extract (235.2 g) designated as SSE.

4.2. Antioxidant Activity by 2,2-diphenyl-1-picrylhydrazyl (DPPH) Radical Scavenging Assay

A DPPH radical scavenging assay was conducted as described by Bersuder et al. [33]. Different SSE concentrations (0.0625, 0.125, 0.25, 0.5, and 1 mg/mL) were mixed with 0.2 mL of 10 mM DPPH (dissolved in methanol to a final concentration of 2 mM). The mixture was allowed to stand in the dark at room temperature for 30 min. Distilled water was used as a substitute for the SSE sample as the background (absorption control), and ascorbic acid (AA) was set as a positive control. The remaining DPPH radical was analyzed on a plate reader (Molecular Devices, Sunnyvale, CA, USA) at 517 nm.

4.3. Antioxidant Activity by ABTS+ Radical Scavenging Assay

An ABTS+ radical scavenging assay was conducted using a total antioxidant capacity assay kit with the ABTS method (Beyotime Institute of Biotechnology, Shanghai, China). An ABTS+ radical solution was prepared by oxidizing the reagents with ABTS+ and oxidation solution with a volume ratio of 1:1. The mixture was allowed to stand in the dark at room temperature overnight. Different SSE concentrations (0.0625, 0.125, 0.25, 0.5, and 1 mg/mL) were mixed with 0.2 mL of ABTS+ radical solution for 10 min. Distilled water was a substitute for the SSE sample as the background (absorption control), and AA was used as a positive control. The remaining ABTS+ radical was analyzed on a plate reader (Molecular Devices) at 620 nm.

4.4. Antimicrobial Assay

A pathogen antagonistic dosage assay was conducted through the disc diffusion method [34]. C. albicans (ATCC10231) was cultivated in Sabouraud dextrose broth at 37 °C for 2 days. The culture was adjusted to obtain a concentration of approximately 108 CFU/mL. One hundred microliters of culture suspension was placed on the petri dishes of Sabouraud dextrose agar. Then, 6 mm paper discs impregnated with 20 µL of the SSE and sasanquasaponin III at the concentration of 100, 50, 25, 12.5, 6.25, 3.125, 1.5625, and 0 mg/mL dissolved in distilled water to obtain the concentration of 2, 1, 0.5, 0.25, 0.125, 0.0625, 0.03125, and 0 mg/disc, respectively. Different concentrations of SSE and sasanquasaponin III from 0 mg to 2 mg were arranged on the plate with C. albicans. The distance between discs was 2 cm. The antibiotic disc (Amphotericin B, ROSCO, Taastrup, Denmark) was used as the positive control. The plates were cultivated at 37 °C, and the clear zone of growth inhibitions was observed. The microbroth dilution was performed in 96-well plate supplemented with Sabouraud dextrose broth [35]. Different concentrations of SSE and sasanquasaponin III (0, 0.0625, 0.125, 0.25, 0.5, 1, and 2 mg/mL) were obtained by a twofold serial dilution in the Sabouraud dextrose broth at a final volume of 50 µL, respectively. The liquid culture of C. albicans was adjusted with OD600 of approximately 0.2. A microbial suspension (50 µL) was added to each well and the mixture (100 µL) was incubated at 37 °C. Afterward, the 96-well plate treated with SSE and sasanquasaponin III was analyzed and determined with a plate reader at 600 nm.

4.5. Detection of Total Polyphenols and Saponins

The content of total polyphenols was measured using the Folin–Ciocalteu method. The SSE sample (0.5 mL) was mixed with 0.5 mL of Folin–Ciocalteu reagent for 5 min. Then, 0.5 mL of 10% sodium carbonate solution was added to the mixture and left for 30 min in the dark. The mixture was centrifuged at 10,000 × g for 10 min at room temperature. The supernatant was analyzed and determined with a plate reader at 760 nm. Gallic acid was used as a positive control to calculate a standard curve (y = 0.0296x − 0.0085; R2 = 0.977). The content of saponins was determined in accordance with previously described methods [36] with modifications. The SSE sample was dissolved in 0.2 mL of 5% vanillin/glacial acetic acid and 0.8 mL of perchloric acid at 60 °C for 20 min. The mixture was cooled down for 5 min, analyzed, and determined with a plate reader at 548 nm. Oleanic acid was used as a positive control to calculate a standard curve (y = 0.5956x + 0.1045; R2 = 0.9987).

4.6. RNA-Seq Analysis of C. Albicans

The cultivated C. albicans broth was introduced to the flesh Sabouraud dextrose medium, with OD600 of approximately 0.2. Different SSE concentrations (0, 0.2, and 0.4 mg/mL) with duplication were added to the broth at 37 °C for 24 h of cultivation. C. albicans specimens were then harvested, and total RNA was obtained using a yeast RNA kit (OMEGA Bio-tek, Guangzhou, China). NanoDrop 2000 (ThermoFisher Scientific, Wilmington, DE, USA) was used for RNA quantification. cDNA synthesis, library construction, cDNA sequencing, and cDNA de novo analysis were performed by the Beijing Genomics Institute (BGI, Shenzen, China). First-strand cDNA was synthesized through reverse transcription with random hexamers followed by end repair, polymerase chain reaction (PCR) amplification, denaturation, and cyclization in accordance with a BGI experimental workflow [37]. cDNA sequencing was performed on a BGISEQ-500 platform, and cDNA reads were analyzed on the basis of the BGI bioinformatics workflow. Sequencing reads were trimmed and screened with SOAPnuke to acquire clean reads. C. albicans SC5314 was used as a reference. Pearson correlation coefficients were determined using cor by the R software. cDNA de novo analysis was conducted through hierarchical indexing for spliced alignment of transcripts (HISAT) for genome mapping [38], RSEM for gene expression analysis [39], cluster for gene expression cluster analysis [40,41], DEGseq for differentially expressed gene (DEG) [42], GO annotation for gene ontology analysis [43], KEGG annotation for DEG pathway analysis [44], and BLAST for gene prediction. The RNA-seq data were deposited at DDBJ/ENA/GenBank under the accession numbers BioProject PRJNA475454 and SRA SRP150296.

4.7. Quantitation of Gene Expression by Real-Time RT-PCR

First-strand cDNA was synthesized with a HiFi-MMLV cDNA kit with oligo (dT) and random hexamers (CWBiotech, Beijing, China) at 42 °C for 1 h and used as a template for real-time PCR. Real-time PCR was performed using an UltraSYBR Mixture (CWBiotech) in a final volume of 12.5 μL (2 × UltraSYBR Mixture 6.25 μL, 10 μM Forward primer 0.25 μL, 10 μM Reverse primer 0.25 μL, cDNA 2 μL, and RNase-free water 3.75 μL) for each reaction in the Roche LightCycler® 480 System (Roche Group, Switzerland). The thermal cycling parameters consisted of initial heating at 95 °C for 15 min, denaturation at 95 °C for 10 s, and annealing and extension at 58 °C for 1 min with amplification of 40 cycles. The primer sets of real-time PCR were shown in Table S4. The eight genes comprising four upregulated and four downregulated genes were randomly selected. Gene expression levels were measured thrice, and the mean of these values was used for analysis. The relative gene expression level was calculated with the 2−ΔΔCT method.

4.8. SEM Analysis

The cultivated C. albicans was spread on a plate containing Sabouraud dextrose agar with or without SSE (0.2 mg/mL) at 37 °C for 40 h cultivation. Then, the agar plate was examined under a field emission scanning electron microscope (FESEM; FEI Quanta 450 FEG FESEM, Hillsboro, OR, USA) equipped with Quorum PP3000T (Quorum Technologies Ltd., Laughton, UK). The agar samples were vitrified using liquid nitrogen slush at −200 °C. The vitrified samples were sublimated at −90 °C for 12 min and then coated with platinum by Quorum PP3000T (Quorum Technologies Ltd.). The sample images were obtained with a FESEM (FEI Quanta 450 FEG FESEM) at an electron beam strength of 15 kV.

4.9. Purification and Identification of SSE by UPLC, ESI-MS, and NMR Analyses

SSE was analyzed through UPLC performed on a Waters ACQUITY UPLC HSS T3 column (2.1 mm × 100 mm, 1.8 μm) (Waters, Milford, MA, USA) with a mobile phase consisting of acetonitrile (A) and 0.1% trifluoroacetic acid water (B) at a flow rate of 0.3 mL/min (0–8 min, 12% A → 20% A; 8–15 min, 20% A → 55% A; 15–18 min, 55% A → 86% A). The detection wavelength was 210 nm, the column temperature was controlled at 30 °C, and the injection volume was 2 μL. The major compound could be separated and obtained with an ODS gel column (180 g, 3.5 cm × 40 cm) (50 μm, YMC, Kyoto, Japan) eluted with various H2O-MeOH (70:30, 50:50, 30:70, and 0:100, each at 3 L) in gradient to yield 13 fractions (Fr 1–13) based on their TLC patterns. Fr 10 (30.3 g) was subjected to a silica gel column (200–300 mesh, Qingdao Marine Chemical Inc., Qingdao, China) and eluted with CH2Cl2-MeOH (100:0, 98:2, 95:5, 9:1, 8:2, 7:3, 6:4, 5:5, and 0:100) in gradient to yield 20 fractions (Sfr 1–20) based on their TLC patterns. Sfr18 (365 mg) was purified through preparative HPLC (Shimadzu chromatograph LC-6AD, Osaka, Japan) by using a reversed-phase C18 column (5 μm, 20 mm × 250 mm; Cosmosil, Kyoto, Japan) and 45% CH3CN-H2O (7 mL/min) to produce compound 1 (52.6 mg, tR 25.5 min). Optical rotations were performed using a JASCO P-1030 automatic digital polarimeter. NMR spectra were obtained on a Bruker AV-600 spectrometer with TMS (Bruker, CA, USA) as an internal standard, and chemical shifts were expressed in δ (ppm). ESI-MS data were determined on a Finnigan LCQ Advantage Max mass spectrometer (Thermo Electron, Lowell, MA, USA). Compound 1 was identified as sasanquasaponin III through ESI-MS and NMR.

5. Conclusions

Our results demonstrated the anticandidal capacity of the stem bark extract from S. superba. RNA-seq and SEM results suggested that SSE could interfere in the cell wall and cell membrane composition, resulting in an irregular twisting and death of cells. Further purification and identification revealed that the major anticandidal compound was sasanquasaponin III. These findings indicated that S. superba might provide an alternative to anticandidal treatment.

Supplementary Materials

The following are available online, Figures S1–S3; Tables S1–S4.

Author Contributions

Conceptualization, C.W., Y.-P.C. and G.-X.Z.; Methodology, C.W., and Y.-P.C.; Validation, C.W., H.-T.W., Q.W., and Y.-P.C.; Formal Analysis, H.-T.W., G.-H.W. and X.Y.; Writing—Original Draft Preparation, C.W. and Y.-P.C.; Writing—Review & Editing, G.-X.Z.; Funding Acquisition, C.W., and G.-X.Z. All authors have read and approved the manuscript.

Funding

This work was supported by the Fujian junior teachers education scientific research project plan under Grant No. JA15812; the Program for Excellent Young Talents in University of Fujian Province; Open Fund of Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research under Grant No. 2016B 030301004; and the National Natural Science Foundation of Xiamen Medical College under Grant No. K2015-10.

Conflicts of Interest

The authors declare no competing financial interest.

References

  1. College, J.N.M. Traditional Chinese Medicine (1st Volume); Shanghai Scientific & Technical Publishers: Shanghai, China, 1985. [Google Scholar]
  2. Xu, W.; Zhou, G.X.; Dai, Y.; Yao, X.S. Chemical constituents in stems of Schima superba. Chin. Trad. Herb. Drugs 2010, 41, 863–866. [Google Scholar]
  3. Zhang, T.J.; Zheng, J.; Yu, Z.C.; Huang, X.D.; Zhang, Q.L.; Tian, X.S.; Peng, C.L. Functional characteristics of phenolic compounds accumulated in young leaves of two subtropical forest tree species of different successional stages. Tree Physiol. 2018, 38, 1486–1501. [Google Scholar] [CrossRef] [PubMed]
  4. Daglia, M. Polyphenols as antimicrobial agents. Curr. Opin. Biotechnol. 2012, 23, 174–181. [Google Scholar] [CrossRef]
  5. Huo, G.H.; Chen, X.T.; Li, Z.M.; Liu, C.F.; Xiao, D.J. Synthesis and structure-activity relationship of theasapogenol galactosides against Magnaporthe oryzae. J. Asian Nat. Prod. Res. 2018, 20, 128–138. [Google Scholar] [CrossRef] [PubMed]
  6. Huo, G.; Zhang, C.; Zhang, Y. Structure elucidation of two triterpenoid saponins from leaves of Schima superba Gardn. et Champ. Lec. Notes Elec. Eng. 2014, 250, 915–922. [Google Scholar]
  7. Xu, W.; Wang, H.; Zhou, G.X.; Yao, X.S. Two new 8-O-4′-type lignans from the stem of Schima superba and their cell growth inhibitory activities against human cancer cell lines. J. Asian Nat. Prod. Res. 2010, 12, 874–878. [Google Scholar] [CrossRef]
  8. Wu, C.; Zhang, R.L.; Li, H.Y.; Hu, C.; Liu, B.L.; Li, Y.L.; Zhou, G.X. Triterpenoid saponins from the root bark of Schima superba and their cytotoxic activity on B16 melanoma cell line. Carbohydr. Res. 2015, 413, 107–114. [Google Scholar] [CrossRef]
  9. Polesello, V.; Segat, L.; Crovella, S.; Zupin, L. Candida infections and human defensins. Protein Pept. Lett. 2017, 24, 747–756. [Google Scholar] [CrossRef]
  10. De Backer, M.D.; Ilyina, T.; Ma, X.J.; Vandoninck, S.; Luyten, W.H.; Vanden Bossche, H. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob. Agents Chemother. 2001, 45, 1660–1670. [Google Scholar] [CrossRef] [PubMed]
  11. Zavrel, M.; White, T.C. Medically important fungi respond to azole drugs: An update. Future Microbiol. 2015, 10, 1355–1373. [Google Scholar] [CrossRef]
  12. Wiederhold, N.P. Antifungal resistance: Current trends and future strategies to combat. Infect. Drug Resist. 2017, 10, 249–259. [Google Scholar] [CrossRef] [PubMed]
  13. Zida, A.; Bamba, S.; Yacouba, A.; Ouedraogo-Traore, R.; Guiguemde, R.T. Anti-Candida albicans natural products, sources of new antifungal drugs: A review. J. Mycol. Med. 2017, 27, 1–19. [Google Scholar] [CrossRef]
  14. Soberon, J.R.; Sgariglia, M.A.; Pastoriza, A.C.; Soruco, E.M.; Jager, S.N.; Labadie, G.R.; Sampietro, D.A.; Vattuone, M.A. Antifungal activity and cytotoxicity of extracts and triterpenoid saponins obtained from the aerial parts of Anagallis arvensis L. J. Ethnopharmacol. 2017, 203, 233–240. [Google Scholar] [CrossRef] [PubMed]
  15. Pereira, J.V.; Freires, I.A.; Castilho, A.R.; da Cunha, M.G.; Alves Hda, S.; Rosalen, P.L. Antifungal potential of Sideroxylon obtusifolium and Syzygium cumini and their mode of action against Candida albicans. Pharm. Biol. 2016, 54, 2312–2319. [Google Scholar] [CrossRef] [PubMed]
  16. Mapfunde, S.; Sithole, S.; Mukanganyama, S. In vitro toxicity determination of antifungal constituents from Combretum zeyheri. BMC Complement. Altern. Med. 2016, 16, 1–11. [Google Scholar] [CrossRef] [PubMed]
  17. Wang, M.Y.; Peng, Y.; Peng, C.S.; Qu, J.Y.; Li, X.B. The bioassay-guided isolation of antifungal saponins from Hosta plantaginea leaves. J. Asian Nat. Prod. Res. 2018, 20, 501–509. [Google Scholar] [CrossRef]
  18. Hayes, B.M.; Bleackley, M.R.; Wiltshire, J.L.; Anderson, M.A.; Traven, A.; van der Weerden, N.L. Identification and mechanism of action of the plant defensin NaD1 as a new member of the antifungal drug arsenal against Candida albicans. Antimicrob. Agents Chemother. 2013, 57, 3667–3675. [Google Scholar] [CrossRef] [PubMed]
  19. Sanglard, D.; Kuchler, K.; Ischer, F.; Pagani, J.L.; Monod, M.; Bille, J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 1995, 39, 2378–2386. [Google Scholar] [CrossRef] [PubMed]
  20. Chauhan, N.; Inglis, D.; Roman, E.; Pla, J.; Li, D.; Calera, J.A.; Calderone, R. Candida albicans response regulator gene SSK1 regulates a subset of genes whose functions are associated with cell wall biosynthesis and adaptation to oxidative stress. Eukaryot. Cell 2003, 2, 1018–1024. [Google Scholar] [CrossRef] [PubMed]
  21. Matsuda, H.; Nakamura, S.; Fujimoto, K.; Moriuchi, R.; Kimura, Y.; Ikoma, N.; Hata, Y.; Muraoka, O.; Yoshikawa, M. Medicinal flowers. XXXI. Acylated oleanane-type triterpene saponins, Sasanquasaponins I-V, with antiallergic activity from the flower buds of Camellia sasanqua. Chem. Pharm. Bull. (Tokyo) 2010, 58, 1617–1621. [Google Scholar] [CrossRef]
  22. Klis, F.M.; de Groot, P.; Hellingwerf, K. Molecular organization of the cell wall of Candida albicans. Med. Mycol. 2001, 39, 1–8. [Google Scholar] [CrossRef] [PubMed]
  23. Nather, K.; Munro, C.A. Generating cell surface diversity in Candida albicans and other fungal pathogens. FEMS Microbiol. Lett. 2008, 285, 137–145. [Google Scholar] [CrossRef] [PubMed]
  24. Kaneko, Y.; Ohno, H.; Kohno, S.; Miyazaki, Y. Micafungin alters the expression of genes related to cell wall integrity in Candida albicans biofilms. Jpn. J. Infect. Dis. 2010, 63, 355–357. [Google Scholar]
  25. Zhao, S.; Wei, P.; Wu, M.; Zhang, X.; Zhao, L.; Jiang, X.; Hao, C.; Su, X.; Zhao, D.; Cheng, M. Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51. Bioorg. Med. Chem. 2018. [Google Scholar] [CrossRef]
  26. Yang, Q.; Gao, L.; Tao, M.; Chen, Z.; Yang, X.; Cao, Y. Transcriptomics analysis of Candida albicans treated with Huanglian Jiedu decoction using RNA-seq. Evid. Based Complement. Alternat. Med. 2016, 2016, 3198249. [Google Scholar] [CrossRef]
  27. Lim, S.M.; Ahn, K.B.; Kim, C.; Kum, J.W.; Perinpanayagam, H.; Gu, Y.; Yoo, Y.J.; Chang, S.W.; Han, S.H.; Shon, W.J.; et al. Antifungal effects of synthetic human beta-defensin 3-C15 peptide. Restor. Dent. Endod. 2016, 41, 91–97. [Google Scholar] [CrossRef]
  28. Raja, V.; Ahmad, S.I.; Irshad, M.; Wani, W.A.; Siddiqi, W.A.; Shreaz, S. Anticandidal activity of ethanolic root extract of Juglans regia (L.): Effect on growth, cell morphology, and key virulence factors. J. Mycol. Med. 2017, 27, 476–486. [Google Scholar] [CrossRef]
  29. Singh, D.; Chaudhuri, P.K. Structural characteristics, bioavailability and cardioprotective potential of saponins. Integr. Med. Res. 2018, 7, 33–43. [Google Scholar] [CrossRef]
  30. De Lucca, A.J.; Boue, S.; Sien, T.; Cleveland, T.E.; Walsh, T.J. Silver enhances the in vitro antifungal activity of the saponin, CAY-1. Mycoses 2011, 54, e1–e9. [Google Scholar] [CrossRef]
  31. Renault, S.; De Lucca, A.J.; Boue, S.; Bland, J.M.; Vigo, C.B.; Selitrennikoff, C.P. CAY-1, a novel antifungal compound from cayenne pepper. Med. Mycol. 2003, 41, 75–81. [Google Scholar] [CrossRef] [PubMed]
  32. Segal, R.; Schlosser, E. Role of glycosidases in the membranlytic, antifungal action of saponins. Arch. Microbiol. 1975, 104, 147–150. [Google Scholar] [CrossRef] [PubMed]
  33. Bersuder, P.; Hole, M.; Smith, G. Antioxidants from a heated histidine-glucose model system. I: Investigation of the antioxidant role of histidine and isolation of antioxidants by high-performance liquid chromatography. J. Am. Oil Chem. Soc. 1998, 75, 181–187. [Google Scholar] [CrossRef]
  34. Torres, K.A.; Lima, S.M.; Ueda, S.M. Activity of the aqueous extract of Schinus terebinthifolius Raddi on strains of the Candida genus. Rev. Bras. Ginecol. Obstet. 2016, 38, 593–599. [Google Scholar] [PubMed]
  35. Mbosso Teinkela, J.E.; Assob Nguedia, J.C.; Meyer, F.; Vouffo Donfack, E.; Lenta Ndjakou, B.; Ngouela, S.; Tsamo, E.; Adiogo, D.; Guy Blaise Azebaze, A.; Wintjens, R. In vitro antimicrobial and anti-proliferative activities of plant extracts from Spathodea campanulata, Ficus bubu, and Carica papaya. Pharm. Biol. 2016, 54, 1086–1095. [Google Scholar] [CrossRef]
  36. Makkar, H.P.S.; Siddhuraju, P.; Becker, K. Plant Secondary Metabolities, 1st ed.; Human Press: Trenton, NJ, USA, 2007. [Google Scholar]
  37. Ju, Y.; Tian, H.; Zhang, R.; Zuo, L.; Jin, G.; Xu, Q.; Ding, X.; Li, X.; Chu, Z. Overexpression of OsHSP18.0-CI enhances resistance to bacterial leaf streak in rice. Rice (NY) 2017, 10, 12. [Google Scholar] [CrossRef]
  38. Kim, D.; Langmead, B.; Salzberg, S.L. HISAT: A fast spliced aligner with low memory requirements. Nat. Methods 2015, 12, 357–360. [Google Scholar] [CrossRef]
  39. Li, B.; Dewey, C.N. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 2011, 12, 323. [Google Scholar] [CrossRef]
  40. Eisen, M.B.; Spellman, P.T.; Brown, P.O.; Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998, 95, 14863–14868. [Google Scholar] [CrossRef] [Green Version]
  41. de Hoon, M.J.; Imoto, S.; Nolan, J.; Miyano, S. Open source clustering software. Bioinformatics 2004, 20, 1453–1454. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Wang, L.; Feng, Z.; Wang, X.; Zhang, X. DEGseq: An R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 2010, 26, 136–138. [Google Scholar] [CrossRef]
  43. Ashburner, M.; Ball, C.A.; Blake, J.A.; Botstein, D.; Butler, H.; Cherry, J.M.; Davis, A.P.; Dolinski, K.; Dwight, S.S.; Eppig, J.T.; et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25–29. [Google Scholar] [CrossRef] [PubMed]
  44. Kanehisa, M.; Goto, S.; Hattori, M.; Aoki-Kinoshita, K.F.; Itoh, M.; Kawashima, S.; Katayama, T.; Araki, M.; Hirakawa, M. From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res. 2006, 34, D354–D357. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the S. superba (SSE) are available from the authors.
Figure 1. Antioxidant activity of SSE. Radical scavenging capability was measured by the DPPH and ABTS+ method. Ascorbic acid (AA) was used as positive control. Results are mean ± S.D. (n = 3).
Figure 1. Antioxidant activity of SSE. Radical scavenging capability was measured by the DPPH and ABTS+ method. Ascorbic acid (AA) was used as positive control. Results are mean ± S.D. (n = 3).
Molecules 24 01587 g001
Figure 2. Anticandidal activity analysis of SSE. The 6 mm paper discs with different concentrations of SSE (0, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, and 2 mg) were placed on the plates with spread C. albicans. The plates were cultured at 37 °C for 24 h, and the growth inhibitions of C. albicans were observed.
Figure 2. Anticandidal activity analysis of SSE. The 6 mm paper discs with different concentrations of SSE (0, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, and 2 mg) were placed on the plates with spread C. albicans. The plates were cultured at 37 °C for 24 h, and the growth inhibitions of C. albicans were observed.
Molecules 24 01587 g002
Figure 3. Anticandidal activity analysis of SSE. The liquid culture of C. albicans was introduced into 96-well plate and different concentrations of SSE (0, 0.03125, 0.0625, 0.125, 0.25, 0.5 and 1 mg/mL) were added. The 96-well plate treated with SSE was cultivated at 37 °C for 24 h and determined by a plate reader at 600 nm. Results are mean ± S.D. (n = 3).
Figure 3. Anticandidal activity analysis of SSE. The liquid culture of C. albicans was introduced into 96-well plate and different concentrations of SSE (0, 0.03125, 0.0625, 0.125, 0.25, 0.5 and 1 mg/mL) were added. The 96-well plate treated with SSE was cultivated at 37 °C for 24 h and determined by a plate reader at 600 nm. Results are mean ± S.D. (n = 3).
Molecules 24 01587 g003
Figure 4. The volcano plots of the differentially expressed genes of C. albicans treated with SSE at the concentrations of 0, 0.2, and 0.4 mg/mL for RNA-seq analysis. The red and blue dots indicated the significantly differentially expressed genes with up-regulation and down-regulation, respectively. The red dot indicates up-regulation (Up); the blue dot indicates down-regulation (Down); the grey dot indicates no differentially expressed genes (no-DEGs).
Figure 4. The volcano plots of the differentially expressed genes of C. albicans treated with SSE at the concentrations of 0, 0.2, and 0.4 mg/mL for RNA-seq analysis. The red and blue dots indicated the significantly differentially expressed genes with up-regulation and down-regulation, respectively. The red dot indicates up-regulation (Up); the blue dot indicates down-regulation (Down); the grey dot indicates no differentially expressed genes (no-DEGs).
Molecules 24 01587 g004
Figure 5. Scanning electron micrographs of C. albicans. (A) A scanning electron micrograph of C. albicans cells after 40 h cultivation at 37 °C. (B) A scanning electron micrograph of C. albicans cells after 40 h of SSE exposure on an agar plate with 0.25 mg/mL at 37 °C.
Figure 5. Scanning electron micrographs of C. albicans. (A) A scanning electron micrograph of C. albicans cells after 40 h cultivation at 37 °C. (B) A scanning electron micrograph of C. albicans cells after 40 h of SSE exposure on an agar plate with 0.25 mg/mL at 37 °C.
Molecules 24 01587 g005aMolecules 24 01587 g005b
Figure 6. Identification of the SSE by UPLC. UV light absorption spectrum of the SSE at the wavelength of 210 nm. (A) UPLC profile of the SSE. (B) UPLC profile of the major compound after purification. (C) UPLC profile of the control without the SSE. The arrow indicated the major compound.
Figure 6. Identification of the SSE by UPLC. UV light absorption spectrum of the SSE at the wavelength of 210 nm. (A) UPLC profile of the SSE. (B) UPLC profile of the major compound after purification. (C) UPLC profile of the control without the SSE. The arrow indicated the major compound.
Molecules 24 01587 g006
Figure 7. The chemical structure of compound 1.
Figure 7. The chemical structure of compound 1.
Molecules 24 01587 g007
Figure 8. Anticandidal activity analysis of sasanquasaponin III. The 6 mm paper discs with different concentrations of sasanquasaponin III (0, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, and 2 mg) were placed on the plates with spread C. albicans. The plates were cultured at 37 °C for 24 h, and the growth inhibitions of C. albicans were observed.
Figure 8. Anticandidal activity analysis of sasanquasaponin III. The 6 mm paper discs with different concentrations of sasanquasaponin III (0, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, and 2 mg) were placed on the plates with spread C. albicans. The plates were cultured at 37 °C for 24 h, and the growth inhibitions of C. albicans were observed.
Molecules 24 01587 g008
Figure 9. Anticandidal activity analysis of sasanquasaponin III. The liquid culture of C. albicans was introduced into 96-well plate and different concentrations of SSE (0, 0.03125, 0.0625, 0.125, 0.25, 0.5, and 1 mg/mL) was added. The 96-well plate treated with sasanquasaponin III was cultivated at 37 °C for 24 h and determined by a plate reader at 600 nm. Results are mean ± S.D. (n = 3).
Figure 9. Anticandidal activity analysis of sasanquasaponin III. The liquid culture of C. albicans was introduced into 96-well plate and different concentrations of SSE (0, 0.03125, 0.0625, 0.125, 0.25, 0.5, and 1 mg/mL) was added. The 96-well plate treated with sasanquasaponin III was cultivated at 37 °C for 24 h and determined by a plate reader at 600 nm. Results are mean ± S.D. (n = 3).
Molecules 24 01587 g009
Table 1. Response to SSE of the genes involved in ergosterol biosynthesis, multidrug resistance and chitin degradation of C. albicans in a dose-dependent manner.
Table 1. Response to SSE of the genes involved in ergosterol biosynthesis, multidrug resistance and chitin degradation of C. albicans in a dose-dependent manner.
FunctionID in GenBankProteinAnnotationSize (aa)log2 Ratio
0.2 mg/mL0.4 mg/mL
Ergosterol biosynthesisXP_711894.1ERG1squalene monooxygenase496−0.30−0.12
XP_713577.1ERG3C-5 sterol desaturase386−1.72−1.84
XP_722612.2ERG7Lanosterol synthase728−0.42−0.73
XP_722678.1ERG8Phosphomevalonate kinase4320.931.18
XP_714460.2ERG9Bifunctional farnesyl-diphosphate farnesyltransferase/squalene synthase4480.260.34
XP_716761.1ERG11Lanosterol 14α-demethylase5280.430.89
XP_722703.1ERG251Methylsterol monooxygenase321−0.98−1.14
XP_715564.1ERG26Sterol-4-alpha-carboxylate 3-dehydrogenase3500.200.14
XP_717931.1ERG273-Ketosteroid reductase3461.221.17
Multidrug resistanceXP_712090.2ATM1ATP-binding cassette Fe/S cluster precursor transporter750−0.46−0.64
XP_718280.1MDL1ATP-binding cassette permease685−0.16−0.85
XP_717637.1MLT1ATP-binding cassette16060.440.96
XP_719165.2MDR1Multidrug resistance protein: plasma membrane MDR/MFS multidrug efflux pump5641.252.27
XP_721489.2HOL1Multidrug resistance protein: MFS transporter5860.921.72
XP_712971.2HOL4Multidrug resistance protein: ion transporter624−0.5−0.73
XP_714342.2QDR3Multidrug resistance protein: membrane transporter697−0.59−0.95
KGU11486.1CDR1Multidrug resistance protein1501−1.65−2.4
Chitin degradationXP_718674.1CHT1Putative Zn(II)2Cys6 transcription factor13891.141.33
XP_721807.2CHT2GPI-linked chitinase 1752−0.51−1.33
XP_722560.1CHT4Chitinase11672.372.62
Table 2. 13C NMR data of compound 1 and sasanquasaponin III (C5D5N, ppm).
Table 2. 13C NMR data of compound 1 and sasanquasaponin III (C5D5N, ppm).
No.1Sasanquasaponin III aNo.1Sasanquasaponin III a
138.838.822-O-Ang 1‴″167.8167.7
226.326.32‴″129.2129.7
389.989.63‴″136.5136.3
439.539.54‴″15.715.7
555.355.45‴″20.720.8
618.518.7GlcA 1′105.2105.3
736.736.62′79.279.3
841.541.63′81.882.5
946.947.04′71.171.1
1036.736.85′76.876.9
1123.723.86′172.3172.3
12124.6124.7Glc 1″102.1102.5
13144.2144.32″76.876.3
1447.547.63″78.078.3
1567.467.44″72.572.4
1674.874.95″78.078.1
1745.045.16″63.463.5
1841.541.6Gal 1‴100.7101.2
1946.946.92‴76.176.1
2031.831.93‴75.975.9
2141.241.44‴71.171.2
2272.472.65‴78.077.3
2327.627.86‴62.261.8
2416.516.6Rha 1″″102.3102.2
2515.715.62″″72.772.5
2617.417.43″″72.472.5
2721.221.24″″73.873.7
2862.762.85″″69.669.7
2933.333.46″″17.918.1
3025.025.1
a The 13C-NMR data of sasanquasaponin III was referenced to the study of Matsuda et al. [21].

Share and Cite

MDPI and ACS Style

Wu, C.; Wu, H.-T.; Wang, Q.; Wang, G.-H.; Yi, X.; Chen, Y.-P.; Zhou, G.-X. Anticandidal Potential of Stem Bark Extract from Schima superba and the Identification of Its Major Anticandidal Compound. Molecules 2019, 24, 1587. https://doi.org/10.3390/molecules24081587

AMA Style

Wu C, Wu H-T, Wang Q, Wang G-H, Yi X, Chen Y-P, Zhou G-X. Anticandidal Potential of Stem Bark Extract from Schima superba and the Identification of Its Major Anticandidal Compound. Molecules. 2019; 24(8):1587. https://doi.org/10.3390/molecules24081587

Chicago/Turabian Style

Wu, Chun, Hong-Tan Wu, Qing Wang, Guey-Horng Wang, Xue Yi, Yu-Pei Chen, and Guang-Xiong Zhou. 2019. "Anticandidal Potential of Stem Bark Extract from Schima superba and the Identification of Its Major Anticandidal Compound" Molecules 24, no. 8: 1587. https://doi.org/10.3390/molecules24081587

Article Metrics

Back to TopTop